ENG/中
老虎证券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
首钢朗泽
成交量:
- -
成交额:
- -
市值:
- -
市盈率:
- -
高:
- -
开:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
3.60亿
香港流通股本:
3.60亿
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
净资产收益率:
-23.25%
总资产收益率:
-5.36%
市净率:
0.00
市盈率(LYR):
- -
市销率:
0.00
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
“人造肉第一股”败走中国市场,国产新质蛋白能否突围?
食品创新研究所
·
2025/12/23
首钢朗泽技术成果正式纳入国家科技传播中心科技成就展数字展品库
中钢网
·
2025/12/17
CCUS赛道潜力释放,首钢朗泽推进合成生物技术产业化
中国财富网
·
2025/08/05
IPO一周要闻丨香港上市井喷 北芯生命上会
投资者网
·
2025/07/20
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02553"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"02553","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02553\",,,,,undefined,":{"symbol":"02553","market":"HK","secType":"STK","nameCN":"首钢朗泽","latestPrice":0,"timestamp":0,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":360000000,"shares":360000000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"02-11 14:20:35","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770797400000},"marketStatusCode":2,"adr":0,"listingDate":1752508800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1770773400000,1770782400000],[1770786000000,1770796800000]],"volumeRatio":0,"greyMarketDetail":{"greyDate":"2025-07-14","greyDateTimestamp":1752422400000,"greyOpeningTime":1752480900000,"greyClosingTime":1752489000000,"showGreyQuote":false,"openProspectusDate":"2025-07-07","listingDate":"2025-07-15"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02553\",,,,,undefined,":{"symbol":"02553","floatShares":360000000,"roa":"-5.36%","roe":"-23.25%","lyrEps":0,"shares":360000000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"0.00","psRate":"0.00","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02553\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02553\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02553\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02553\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02553","date":"2025-07-18","current":-42.237026,"percent":0.5,"low":-42.242804,"twenty":-42.238182,"median":-42.237026,"eighty":-42.189414,"high":-42.163874,"avg":-42.215306,"sd":0.030742,"marketCap":6344867062},"quantilePoints":[{"date":"2025-07-18","current":-42.237026,"twenty":-42.238182,"median":-42.237026,"eighty":-42.189414,"marketCap":6344867062}],"updateTime":1770790835560},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02553\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593494616","title":"“人造肉第一股”败走中国市场,国产新质蛋白能否突围?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593494616","media":"食品创新研究所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593494616?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 13:24","pubTimestamp":1766467482,"startTime":"0","endTime":"0","summary":"2019年5月,Beyond Meat在纽约证券交易所上市,成为全球“人造肉第一股”。国际上另一家知名“人造肉”公司Impossible Foods在2020年初回应《牧食记》问询时亦表示,虽然当时没有具体的计划要在中国大陆上市,但这肯定是公司想尽快实现的一个目标。综合各个渠道的反馈来看,“人造肉”市场遇冷的主要原因包括产品口感与真肉存在差距、价格缺乏竞争力等。截至12月18日收盘,Beyond Meat的股价已跌至1.04美元,公司总市值仅为4.72亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223132842a6c47321&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223132842a6c47321&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02553"],"gpt_icon":0},{"id":"2592994760","title":"首钢朗泽技术成果正式纳入国家科技传播中心科技成就展数字展品库","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994760","media":"中钢网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994760?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 11:02","pubTimestamp":1765940540,"startTime":"0","endTime":"0","summary":"北京首钢朗泽科技股份有限公司获中国环境科学学会推荐,在会上正式发布“含碳工业尾气生物发酵制乙醇及微生物蛋白技术”。该项技术作为重要成果,正式纳入国家科技传播中心科技成就展数字展品库,标志着其创新贡献获得国家级平台的高度认可与永久珍藏。金涌院士表示,首钢朗泽技术不仅是我国落实“双碳”战略、破解工业绿色转型瓶颈的关键创新,更是合成生物学与CCUS技术融合领域的标志性突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217110722a6ac00f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217110722a6ac00f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02553"],"gpt_icon":0},{"id":"2557635721","title":"CCUS赛道潜力释放,首钢朗泽推进合成生物技术产业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2557635721","media":"中国财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557635721?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 13:54","pubTimestamp":1754373250,"startTime":"0","endTime":"0","summary":"随着全球减碳政策的密集出台,CCUS行业迎来爆发式增长机遇,而首钢朗泽凭借合成生物技术的创新应用,在这一赛道上展现出强劲的引领力。合成生物技术落地生根,首钢朗泽打造行业标杆在CCUS行业加速扩张的浪潮中,首钢朗泽凭借合成生物技术的深度应用,构建起独特的竞争优势。作为CCUS行业的创新先锋,首钢朗泽以合成生物技术的产业化实践,为全球减碳事业提供了可复制的解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805135846a475e33d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805135846a475e33d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02553"],"gpt_icon":0},{"id":"2552448888","title":"IPO一周要闻丨香港上市井喷 北芯生命上会","url":"https://stock-news.laohu8.com/highlight/detail?id=2552448888","media":"投资者网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552448888?lang=zh_cn&edition=fundamental","pubTime":"2025-07-20 08:01","pubTimestamp":1752969691,"startTime":"0","endTime":"0","summary":"上交所上市审核委员会定于7月18日召开2025年第23次上市审核委员会审议会议。值得一提的是,继禾元生物过会后,北芯生命是本月第二家选取第五套标准的科创板IPO过会企业。目前,以该标准排队的科创板IPO企业共5家:除北芯生命外,恒润达生尚未上会;禾元生物、思哲睿、必贝特已提交注册。发行人通过上市委会议后,交易所将相关资料报送证监会,等待证监会作出同意或者不予注册的决定,只有获得证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/20080151828246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0155","002709","301536","688008","159982","688343","ADC","LU0320764243.SGD","LU0708995153.HKD","300568","BK1240","LU0229945570.USD","06610","01908","BK4231","399300","LU0128522744.USD","BK0201","BK1137","LU0543330566.HKD","BK0077","BK0229","BK0028","LU2039709279.SGD","BK0231","09887","BK4080","02553","LU0029874905.USD","BK0214"],"gpt_icon":1}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02553\",params:#limit:6,delay:false,,,undefined,":[]}}